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ABSTRACT
Background: To investigate the methods of percutaneous transcatheter interventions for combined congenital 
heart disease and to evaluate its efﬁ  cacy in children. Materials and Methods: Thirty cases (ages 3 days-13.5 
years, body weight 3-35 kg) that underwent two multiple transcatheter interventions for combined or solitary 
congenital heart disease were retrospectively analyzed and presented. Results: A total of 61 transcatheter 
interventions were performed in 30 patients as combined procedures. In 29 patients, two different procedures 
were combined in the same session, in remaining one patient, combination of three interventions were 
performed in the same catheter session. Interventions performed in combined procedures were as follows: 
Coarctation balloon angioplasty in 12 cases, pulmonary balloon valvuloplasty in 10, PDA coil embolization 
in 10, aortic balloon valvuloplasty in 8, VSD closure in 5, ASD closure in 4, ductal stent implantation in 4, 
palliative pulmonary balloon valvuloplasty in 3, recanalization and angioplasty of the systemic-pulmonary 
shunt in 2, balloon atrial septostomy in one, aortic coarctation stent implantation in one, coil embolization of a 
pulmonary lobar sequestration in one and pulmonary valve perforation plus pulmonary balloon valvuloplasty 
in one were performed as ﬁ  rst or second procedure. There was no mortality or major morbidity in relation to 
combined procedures. Conclusion: Multiple transcatheter interventions in the same session are feasible, safe 
and effective with satisfactory good results. Second intervention may be performed as complementary procedure 
or independently to the ﬁ  rst intervention.
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INTRODUCTION
Advances in pediatric interventional cardiac 
catheterization have changed the therapeutic strategy for 
many patients with congenital heart disease. Since the ﬁ  rst 
attempt of palliation of transposition of the great arteries 
by transcatheter technique,[1] the efﬁ  ciency and safety  of 
transcatheter interventional treatment have been greatly 
improved. Nowadays, many congenital cardiac diseases can 
be treated by transcatheter interventional procedures.[2-4] 
Moreover for some congenital lesions, such as pulmonary 
valvular stenosis,[5] transcatheter therapy nearly replaced 
the surgery. 
For combined congenital cardiovascular defects, the 
efﬁ  cacy and safety of transcatheter interventional therapy 
has been a topic of increasing concern. By the late 
nineties, reports of an interventional procedure prior to 
surgery for combined defects emerged, but there are only 
a few case reports where multiple defects were addressed 
simultaneously by interventional procedures.[1] 
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We present our experience of percutaneous transcatheter 
interventions for combined congenital heart diseases 
and discuss the efﬁ  cacy and safety of these simultaneous 
procedures in children.
MATERIALS AND METHODS 
From the years 2004-2010, a total of 30 children (15 
boys, 15 girls) underwent combined transcatheter 
interventions for multiple congenital heart defects. After 
routine physical and radiological evaluation, transthoracic 
echocardiographic examination was performed to all 
patients using Vivid-3 (General Electric) machine with 3.5 
and 5 MHz transducers. Diagnostic cardiac catheterization 
and all interventional procedures were performed under 
general anesthesia. 
A total of 61 transcatheter interventions were performed 
in 30 patients as combined procedures. In 29 patients two 
different procedures were combined in the same session; in 
remaining one patient combination of three interventions 
were performed in the same catheter session. Interventions 
performed in combined procedures were as follows: 
Balloon angioplasty for coarctation to 12 children, 
pulmonary balloon valvuloplasty to 12 patients, 
transcatheteter coil embolization to 10 children, aortic 
balloon valvuloplasty to eight patients, ventricular septal 
defect (VSD) closure to ﬁ  ve patients, atrial septal defect 
(ASD) closure to four patients, ductal stent implantation to 
four patients, recanalization of occluded Blalock-Taussiq 
shunt in two children, perforation of the pulmonary valve 
in one child, coil embolization of pulmonary sequestration 
in one child, balloon atrial septostomy to one child, and 
stent implantation for coarctation of the aorta in one child. 
For valvular stenosis, peak systolic pressure gradients 
and for aortic coarctation, peak-to-peak systolic pressure 
gradients were determined before and after valve dilatation 
and/or aortic coarctation angioplasty and stenting.
Because the whole defects are small, non-detachable 
Gianturco coils were used for coil embolization of the 
patent ductus arteriosus. According to the nature of the 
defect and to the accompanying disease coil implantation 
were performed from arterial or venous sides of the ductus 
arteriosus. 
Defect occlusion for ASDs and VSDs were performed 
under transesophageal or transthoracic echocardiographic 
guidance. All children with implanted devices received 
intravenous heparin (100 IU/kg) and prophylactic 
antibiotics during the procedure. Antithrombotic dose of 
acetylsalicylic acid was prescribed to all children with device 
closure for 6 months.
Ductal stent implantation was performed transarterially 
with standard coronary type stent in patients with 
pulmonary atresia to access effective flow to the 
pulmonary tree. After implantation of stent to ductal 
location and being sure of effective pulmonary ﬂ  ow, 
retrograde pulmonary valve perforation with a guide-
wire and then balloon valvuloplasty to perforated valve 
were performed in selected cases. Intravenous heparin 
and acetylsalicylic acid were used sequentially after stent 
implantation procedure. 
Statistical evaluation
Differences among pre- and post-procedure in cases 
who performed balloon angioplasty for coarctation of 
aorta, aortic balloon valvuloplasty and pulmonary balloon 
valvuloplasty were analyzed separately with the Student’s 
t test. P-values below 0.05 were considered statistically 
signiﬁ  cant. 
RESULTS
Study population
The mean age of our whole study population was 36.3 ± 
48.1 months (4 days–13.5 years) and the mean body weight 
was 12.4 ± 9.8 kg (2.2-35 kg). Age, weight and diagnosis 
of the whole cases is shown in Table 1.
Procedural features
Coarctation balloon angioplasty was the most performed 
procedure in our study population, performed in 12 cases. 
Coarctation balloon angioplasty was performed as the 
former procedure in four cases, as the latter procedure 
in eight cases. Lesions were native in all cases [Table 2]. 
The mean age of these cases was 25.5 ± 48.9 months (2 
days-11.5 years) and mean weight was 9.7±10.6 kg’s (3-35 
kg). The mean gradient across the lesion was 23.2 ± 13.2 
mmHg (1-44 mmHg) before and 7.7 ± 4.2 mmHg (0-15 
mmHg) after balloon angioplasty (P=0.001). 
Pulmonary balloon valvuloplasty was performed as the 
former procedure in eight cases [Table 2]. The mean 
total transcatheter gradient across the pulmonary valve 
in the cases except in one who was performed palliative 
pulmonary valvuloplasty was 75.4 ± 28.7 mmHg (44-131 
mmHg) before valvuloplasty and 14.1 ± 8.3 mmHg (7-30 183
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mmHg) after valvuloplasty in these patients (P=0.001). 
In a 24-days old baby weighing 2.2,  with the diagnosis 
of hypoplastic tricuspid valve, severe tricuspid stenosis, 
hypoplastic right ventricle and critical pulmonary stenosis; 
pulmonary balloon valvuloplasty was performed with a 
4-mm coronary balloon ﬁ  rst, and then the procedure was 
repeated with a 7-mm standard balloon. The transpulmonic 
gradient was decreased, but oxygen saturation was between 
70 and 80% after valvuloplasty. Ductal implantation of a 3.5 
mm coronary stent was performed as a second procedure 
to achieve satisfactory oxygenation by an extra increase in 
pulmonary blood ﬂ  ow. The oxygen saturation at last was 
90 % [Table 2].
In another 4-days old baby, with critical pulmonary stenosis, 
despite a decrease of total transpulmonic gradient to 
25 mmHg after pulmonary balloon valvuloplasty, the 
compliance of right ventricle and systemic saturation did 
not improve. To overcome 
this situation, a 3.5 mm coronary stent was implanted 
retrogradely into ductus and systemic oxygen saturation 
increased from 62 to 92% [Table 2]. 
Pulmonary balloon valvuloplasty was performed as the 
second procedure in three cases (pulmonary valvuloplasty 
for antegrad palliation in two cases), and as the third 
procedure in one [Table 2]. In two patients with Fallot’s 
tetralogy, recanalization of previously constructed 
and obstructed surgical aortopulmonary shunt and 
then dilatation with a 4-mm coronary balloon was 
Table 1: Age, weight and diagnosis of the whole cases
Cases Sex Age Weight (Kg)  Diagnosis
1 ANB F 1 month  3 AoCo, Bicuspid AV, AS, LVH, PFO
2 SY M 6 months  7.5 Bicuspid AV, AS, AoCo
3 EE M 11.5 years 35 AoCo, PS 
4 MK M 10 years  28.5 AoCo, Pm VSD, AI (mild)
5 SNC F 42 days 3.5 Severe AS, discrete AoCo, PFO, LVH, severe PH
6 MM M 5 months 6.8 AoCo, bicuspid AV, AS, LVH, trivial mitral insufﬁ  ciency
7 SEB M 7 days 3.8 AoCo, bicuspid AV, AS, LVH, PDA, PFO, severe PH
8 SP F 2 months 3,5 Dextro-transposition of great arteries, VSD, AoCo, PFO, PDA 
9 AB M 15 months  8 AoCo, PDA, bicuspid AV, AS (mild)
10 NA F 17 months  10 Operated VSD+ASD+PDA, residual PDA, AoCo (mild) 
11 SC F 4 years  16 PS, PDA
12 AA M 13.5 years  35 Pm VSD, VSA, AV prolapse, PDA
13 RB M 5.5 years  22 Pm VSD, VSA , PDA
14 HG F 6.5 years 25.5 Secundum ASD, PDA, bicuspid AV, trivial AI
15 HT M 3.5 months 8.5 Bicuspid AV, AS, PS, Biventricular hypertrophy, PFO
16 NAO M 20 days  3.8 Shone complex, critic AoCo, mitral stenosis (mild), bicuspid AV, AS, Pm VSD, 
PDA, left ventricular hypoplasia (mild)
17 EK F 2.5 years 8.5 TOF, right arcus aorta, right modiﬁ  ed BT shunt (Obstructed)
18 KA F 4 days  3.4 Critic PS, PFO, PDA
19 BNK F 24 days 2.2 Hypoplastic tricuspid valve, severe tricuspid stenosis, hypoplastic bipartiete right 
ventricle, critic PS, small muscular VSD, AI, large secundum ASD, PDA
20 ST F 14.5 months 9.5 Pulmonary atresia with intact ventricular septum, PDA
21 YEC M 1 month 3.2 AoCo, Pm VSD , left ventricle-right atrium communication, left ventricular systolic 
dysfunction, PFO, pulmonary sequestration
22 ENV F 23 months 11 PDA (mild size), secundum ASD
23 MS M 8,5 years 24 Semidysplastic pulmonary valve, severe PS, secundum ASD, right ventricular 
hypertrophy
24 FC F 8.5 years 19 Bicuspid AV, severe AS, long segment AoCo, LVH
25 ZNT F 13 months 10,6 PS, PDA (Small-Moderate)
26 BM M 13 months 8 Pm VSD (Moderate), VSA, PDA 
27 EK F 6 months 6 Double inlet left ventricle, double outlet left ventricle, PS, Left modiﬁ  ed BT shunt 
(Obstructed)
28 YB M 3 years 12,3 Down Syndrome, TOF, Left modiﬁ  ed BT shunt (Obstructed)
29 KK F 10.2 years 23 PS, Secundum ASD
30 BE M 11 years 44 Pm VSD, VSA, AV prolapse, AI (mild), PDA (small)
F: Female, M: Male, AoCo: Aortic coarctation, AI: Aortic insufﬁ  ciency, AS: Aortic stenosis, ASD: Atrial septal defect, AV: Aortic valve, LVH: Left ventricular hypertrophy, PDA: 
Patent ductus arteriosus, PFO: Patent foramen ovale, PH: Pulmonary hypertension, PS: Pulmonary stenosis, Pm: Perimembranous, TOF: Tetralogy of Fallot, VSD: Ventricular 
septal defect, VSA: Ventricular septal aneurysm.Turkay, et al.: Combined interventional treatment
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Figure 1: Coil embolization of PDA using Gianturco non-detachable 
coil as ﬁ  rst or second procedure
Figure 2: Closing of VSD using Cook’s detectable coil (5 mm’of 
diameter with 5 loop) and left ventriculogram shortly after implantation 
of coil
performed, but this much dilatation of the shunt could 
not be sufﬁ  cient enough to increase patient’s oxygenation. 
Palliative pulmonary balloon valvuloplasty was performed 
as a second procedure with a sufﬁ  cient increase in patient’s 
oxygenation [Table 2]. In another case with pulmonary 
atresia with intact ventricular septum, a 4-mm coronary 
stent was implanted ﬁ  rstly, but the oxygen saturation did 
not increase efﬁ  ciently. For this reason, ﬁ  rstly pulmonary 
valve was perforated using guidewire through ductal 
stent, and then pulmonary balloon valvuloplasty was 
performed as third procedure. After the last procedure, 
the oxygen saturation increased up to 75-80% (Table 2, 
Movie 1 and 2).
PDA’s were embolizated by using Gianturco non-detachable 
coils in 10 cases. The mean size of the PDA on aortogram 
was 1.9±0.3 mm (1.5–2.5 mm). The mean diameter of the 
coils used in PDA closure was 4.2 ± 0.9 mm (3-5 mm). The 
stenosis in left pulmonary artery due to coil embolization 
was not detected in any of the patients. Full occlusion 
was seen in 9 patients, while a minimal residual shunt was 
detected in one patient [Figure 1, Table 2]. 
The mean age of the patients that were carried out aortic 
balloon valvuloplasty was 16.9 ± 3.8 months (4 days-103 
months) and the mean weight was 7.4 ± 5.4 kg (3-19 kg). 
The mean annulus diameter was 9.5 ± 3.1 mm (6.3-14.5 
mm), maximum systolic gradient was 71.7 ± 31.4 mmHg 
(19-115 mmHg) and mean systolic gradient was 45 ± 11.8 
mmHg (32-62 mmHg) in transthoracic echocardiography. 
Aortic annulus diameter measured at catheterization 
laboratory was 8.4 ± 3.5 mm (4.5-14.4 mm). The mean 
diameter of balloon was 8.2 ± 3.1 mm (5-14 mm). Peak-
to-peak transaortic gradient before procedure was 54.7 
± 35.6 mmHg (5-118 mmHg) at cath-lab. Peak-to-peak 
gradient was 20.5 ± 12.1 mmHg (0-36 mmHg) after 
balloon valvuloplasty (P=0.001). Mild aortic regurgitation 
in two cases and moderate aortic regurgitation in one were 
detected after valvuloplasty procedure [Table 2].
VSDs were closed by using coil in one, Amplatzer duct 
occluder 1 in two patients, Amplatzer duct occluder 2 in 
one patient and Cardi-O-Fix muscular VSD occluder in 
one patient [Table 2, Figure 2-5a-b]. Pulmonary arterial 
pressures were normal in all patients, but there were left 
heart dilatation. There was mild aortic insufﬁ  ciency before 
the procedure in one case. In other case, too, there was 
ventricular septal aneursym, aortic valve prolapse and mild 
aortic insufﬁ  ciency. The ratio of pulmonary to systemic 
ﬂ  ow (Qp/Qs) was not more than 1, 5 in these two cases. 
In the case who has only mild aortic insufﬁ  ciency, the 
defect was closed by using Cook’s detectable coil (5 mm of 
diameter with 5 loop) with the guidance of transthoracic 
echocardiography. In the case of a patient who has 
ventricular septal aneursym, aortic valve prolapse and 
mild aortic insufﬁ  ciency, the defect in ventricular septal 
aneursym in stead of true defect was closed by using 6 
millimeter Cardi-O-Fix muscular VSD occluder with the 
guidance of transthoracic echocardiography. The aortic 
regurgitation decreased from mild to trivial amount after 
procedure in both cases. 
Qp/Qs was more than 1, 5 in the other three cases. They 
had ventricular septal aneurysms. These defects were closed 
by using Amplatzer duct occluder 1 and 2 with the guidance 
of transthoracic echocardiography. In one of them, a 
complete atrioventricular block was developed in a short 
time after device implantation. There was no residual shunt 
on left ventriculogram in the long axial oblique projection 
except one patient. Minimal residual shunt was observed 
in case who was used Amplatzer duct occluder 2 after 
procedure [Figures 4-5b]. 
There observed no tricuspid regurgitation related to VSD 
closure in any of the patients. We did not detect any 185
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Table 2: First and second procedures and their outcomes
Cases First procedure  Second procedure Outcomes
1 ABV Transaortic gradient decreased from 56 to 23 mmHg.
AoCo gradient decreased from 44 to 12 mmHg.
2 ABV Transaortic gradient decreased from 64 to 30 mmHg. 
Aortic coarctation gradient decreased from 12 to 7 mmHg. 
3 PBV Total transpulmonic gradient decreased from 46 to 8 mmHg. 
AoCo gradient decreased from 18 to 9 mmHg.
4 VSD closure using coil BAP VSD was closured totally. AI was reduced from mild to trivial.
AoCo gradient decreased from 30 to 10 mmHg.
5 ABV Transaortic gradient decreased from 45 to 20 mmHg. Mild AI was developed. 
AoCo gradient decreased from 15 to 5 mmHg.
6 ABV Transaortic gradient decreased from 40 to 20 mmHg. 
AoCo gradient decreased from 32 to 11 mmHg.
7 ABV Transaortic gradient decreased from 30 to 25 mmHg. 
AoCo gradient decreased from 7 to 5 mmHg.
8 BAS SaO2 increased from 68 to 84%, and interatrial gradient decreased from 6 to 2 
mmHg after BAS. AoCo gradient decreased from 22 to 15 mmHg.
9 BAP AoCo gradient decreased from 30 to 4 mmHg. PDA was closed totally. 
10 BAP AoCo gradient decreased from 42 to 11 mmHg. PDA was closed totally.
11 PBV Total transpulmonic gradient decreased from 60 to 25 mmHg. 
Minimal residual shunt was observed from PDA.
12 VSD closure using ADO Coil embolization 
of PDA
Both defects were closed totally. Complet atrioventricular block was developed.
13 VSD closure using ADO Both defects were closed totally.
14 ASD closure using ASO Both defects were closed totally.
15 PBV ABV  Transaortic gradient decreased from 70 to 10 mmHg. Mild AI was developed. 
Total transpulmonic gradient decreased from 87 to 30 mmHg.
16 BAP In this case who has systolic dysfunction, indentation lost during both procedures. 
However, at the beginning and end of both procedures, there was no gradient in 
both lesions due to systolic dysfunction. 
17 Modiﬁ  ed BT shunt 
recanalisation
 Palliative PBV SaO2 increased from 60 to 75% after recanalization of BT shunt. 
SaO2 increased to 81% after second procedure.
18  PBV Ductal stenting Despite total transpulmonic gradient decreased to 25 mmHg the compliance of 
right ventricle and saturation didn’t improve, and ductal stenting was performed. 
SaO2 increased from 62 to 92% after ductal stenting.
19 SaO2 increased from 70 to 80 % and total transpulmonic gradient decreased to 
20 mmHg after ﬁ  rst procedure. SaO2 increased from 80 to 90 % after second one. 
20 Ductal stenting Perforation of the PV
 and than PBV
SaO2 increased from 40 to 65% after ductal stent implantation. 
SaO2 increased to 75%-80% after third procedure.
21 BAP Coil embolization 
of the pulmonary 
sequestration
AoCo gradient decreased from 42 to 11 mmHg. 
Pulmonary sequestration was embolizated successfully. 
22 Coil embolization of PDA ASD closure using 
CSO
Both defects were closed totally.
23 PBV Transpulmonary gradient decreased from 128 to 7 mmHg. 
ASD was closed totally. 
24 ABV  Stent implantation for 
AoCo
Transaortic gradient decreased from 118 to 45 mmHg. Moderate AI was 
developed.
 AoCo gradient decreased from 36 to 0 mmHg.
25 PBV Coil embolization of 
PDA
Total transpulmonic gradient decreased from 78 to 11 mmHg.
PDA was closed totally.
26 VSD closure 
using ADO II
Coil embolization of 
PDA
Minimal residual shunt was observed from VSD.
PDA was closed totally.
27 Palliative PBV Ductal stenting SaO2 increased to 72% after ﬁ  rst procedure, and increased to 78 after second 
one.
28 Modiﬁ  ed BT shunt 
recanalisation
Palliative PBV SaO2 increased from 63 to 74% after ﬁ  rst procedure, and increased to 96 after 
second one.
29 ASD closure using CSO PBV ASD was closed totally. Transpulmonary gradient decreased from 53 to 15 mmHg.
30 VSA closure using 
muscular VSD occluder
Coil embolization of 
PDA
Both defects were closed totally. 
AI was reduced from mild to trivial. 
ABV: Aortic balloon valvuloplasty, BAP: Balloon angioplasty of aortic coarctation, PBV: Pulmonary balloon valvuloplasty, VSD: Ventricular septal defect, BAS: Balloon atrial 
septostomy, PDA: patent ductus arteriosus, SaO2: Saturation, ADO: Amplatzer duct occluder, ASO: Amplatzer septal occluder, PV: Pulmonary valve, CSO: Cardi-O-Fix atriyal 
septal occluder, BT:Blalock-Taussig.Turkay, et al.: Combined interventional treatment
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increase in the severity of aortic regurgitation related to 
the procedure in any patient. 
Ductal stent implantation was performed in four cases 
for augmentation of pulmonary blood pressure and to 
increase the patient’s oxygenation [Table 2, Figure 6]. In 
two patients with critical pulmonary stenosis, the stent 
implantation alone was enough for an optimal result. But, 
in a patient with pulmonary atresia with intact ventricular 
septum, oxygen saturation did not increase efﬁ  ciently 
after stenting of ductus. The patient had pulmonary 
atresia of membranous type and a well-developed right 
ventricle, and did not have any right ventricle-dependant 
coronary circulation. In a retrograde fashion, atretic 
pulmonary valve was perforated with a guide-wire and 
then pulmonary balloon valvuloplasty was performed with 
resultant antegrade pulmonary ﬂ  ow [Figure 7]. 
In other case who had double inlet left ventricle, double 
outlet left ventricle, left modiﬁ  ed BT shunt (obstructed), 
PDA (small), in addition to palliative pulmonary balloon 
valvuloplasty, ductal stenting was performed due to 
oxygen saturation did not increase efﬁ  ciently after the ﬁ  rst 
procedure [Table 2]. 
ASD closure using Amplatzer or Cardi-O-Fix atrial septal 
Figure 3: Closing of VSD using Amplatzer duct occluder 1 and left 
ventriculogram shortly after implantation of device
Figure 5a: Closing of VSD using Cardi-O-Fix muscular VSD occluder 
and checking of residual shunt shortly after releasing the device on 
left ventriculogram in the long-axial oblique projection
Figure 6: Ductal stenting after pulmonary balloon valvuloplasty in a 
case with critic pulmonary stenosis
Figure 7: Perforation of atretic pulmonary valve using a guide-wire and 
then pulmonary balloon valvuloplasty after ductal stenting
Figure 5b: Closing of VSD using Cardi-O-Fix muscular VSD occluder 
and checking of the aortic insufﬁ  ciency shortly after releasing the device 
on transthoracic echocardiographic imaging
Figure 4: Closing of VSD using Amplatzer duct occluder 2 and 
checking of the aortic insufﬁ  ciency shortly after releasing the device 
on transthoracic echocardiographic imaging187
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occluder was performed with ductal coil embolization in 
two patients, and with pulmonary balloon valvuloplasty in 
two patients [Table 2]. The sizes of ASD’s were moderate, 
and Qp/Qs calculated at cath-lab were more than 1.5 in all 
cases. They found no residual shunt on anjiocardiogram in 
any patient after procedure. 
Balloon atrial septostomy was performed successfully in 
one, coil embolization of pulmonary sequestration in one, 
stent implantation to a long-segment coarctation in one, 
and recanalization and balloon angioplasty to a surgically 
created aortopulmonary shunt in two patient [Table 2]. 
The mean procedural time was 97.9 ± 43.4 minutes (58-240 
minutes) and the mean ﬂ  uoroscopy time was 27.6 ± 10.9 
minutes (11–47 minutes). 
There was no mortality related to any combined procedure.
Patient symptoms
Most of the patients who underwent the combined 
transcatheter procedure were asymptomatic. Six patients 
(under 3 months of age) with aortic coarctation who had 
balloon angioplasty done all had pulmonary hypertension, 
and two patients had left ventricular systolic dysfunction. 
Respiratory distress was present in all patients. Two-day-
old patient with Shone’s Complex presented with slight 
confusion, paleness and acrocyanosis. Another 6.5-year-
old patient with a wide secundum ASD and narrow PDA 
had stage 2 dyspnea according to NYHA criteria. After 
balloon angioplasty was performed on ﬁ  ve patients with 
aortic coarctation, their symptoms subsided completely. 
In the patient with Shone’s Complex the tachypnea and 
cardiac deﬁ  ciency were only partially alleviated. Patients 
with prominent cyanosis and critical pulmonary stenosis or 
cyanotic congenital heart disease saw considerable decrease 
in cyanosis after the procedure. 
Follow-up
The mean follow-up time and the mean number of follow-
up were 22.4 ± 24.7 months (1 days-72 months) and 5.6 ± 
3.8 times (once-13 times), respectively. 
Recoarctation was developed in four out of 12 coarctation 
patients (33.3%). Diagnoses, ages of combined procedure 
and redo balloon angioplasty, and outcomes of redo balloon 
angioplasty of these cases have been shown in Table 3. In 
one of them, 6 months after redo balloon angioplasty of 
aortic coarctation, recoarctation was developed again, and 
this patient was sent to surgery for resection and end-to-
end anastomosis. 
In an infant with Shone’s complex, systolic dysfunctions 
and pulmonary hypertension were improved partially 
in the first week of combined procedure including 
coarctation angioplasty and aortic balloon valvuloplasty. 
But this patient had mild left ventricular hypoplasia and 
repeated echocardiographic examinations revealed tunnel 
type stenosis at left ventricular outﬂ  ow tract in addition 
to aortic valvular stenosis. At follow-up, severity of 
subaortic stenosis increased. Balloon angioplasty for aortic 
coarctation was performed again at 3-weeks-old of his 
life due to persisted systolic dysfunction and pulmonary 
hypertension. After second balloon angioplasty, systolic 
function improved highly (ejection fraction increased from 
39 to 52%), but pulmonary hypertension did not decrease. 
Surgery was planned for subaortic stenosis, because of 
a maximum gradient of 96 mmHg (mean 63 mmHg) 
Table 3: Patients underwent redo balloon angioplasty for aortic coarctation and outcomes of the redo intervention
Cases Diagnosis Age of 
combined 
procedure 






Age of redo 
intervention
Outcomes 
1 ANB AoCo, Bicuspid AV, AS, LVH, PFO  1 month ABV BAP 7 months AoCo gradient decreased 
from 30 to 16 mmHg.
2 SEB AoCo, bicuspid AV, AS, LVH, PDA, PFO, 
severe PH
7 days ABV BAP 16 months AoCo gradient decreased 
from 32 to 8 mmHg.
3 NAO Shone complex, critic AoCo, mitral 
stenosis (mild), bicuspid AV, AS, Pm VSD, 
PDA, left ventricular hypoplasia (mild), 
systolic dysfunction
2 days BAP ABV 3 weeks Systolic dysfunction 
improved highly, but 
pulmonary hypertension 
did not decrease.
4 YEC AoCo, Pm VSD , left ventricle-right 
atrium communication, left ventricular 
systolic dysfunction, PFO, pulmonary 
sequestration





3.5 months AoCo gradient decreased 
from 56 to 5 mmHg.
AoCo, Aortic coarctation; AV, Aortic valve; AS, Aortic stenosis; ABV, Aortic balloon valvuloplasty; BAP, Balloon angioplasty of aortic coarctation; LVH, Left ventricular 
hypertrophy; PDA, Patent ductus arteriosus; PFO, Patent foramen ovale; PH, Pulmonary hypertension; Pm, perimembranous; VSD, Ventricular septal defect.Turkay, et al.: Combined interventional treatment
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measured at last examination, but this patient died before 
surgery. 
In the cases underwent balloon atrial septostomy 
and balloon angioplasty for aortic coarctation, 
arterial switch, VSD closure and coarctation repair-
resection and end-to-end anastomosis were performed 
at 1-month age. Because of neopulmonary valve stenosis 
developed, this patient was operated again at 4 years of 
age. 
We considered magnetic resonance imaging of arcus and 
descending aorta, although we did not detect and aneurism 
formation after coarctation angioplasty in any patient. 
Pulmonary restenosis did not occur in follow-up of any 
patient who underwent pulmonary balloon valvuloplasty 
except palliative pulmonary valvuloplasty as a ﬁ  rst or 
second procedure. Two patients with Fallot’s tetralogy 
underwent palliative pulmonary balloon valvuloplasty was 
totally corrected after a non-eventful follow-up period. 
In one of the two patients with critic pulmonary stenosis 
underwent ductal stenting, it is detected that the ﬂ  ow of 
ductal stent occluded at follow-up. The oxygen saturation 
of this case was good, and there was no gradient through 
right ventricular outﬂ  ow tract. In the other case with 
critic pulmonary stenosis, tricuspid valve was hypoplastic 
and right ventricle was hypoplastic and bipartiete. During 
follow-up, while pulmonary restenosis has not been 
observed and the ﬂ  ow of ductal stent has been persisted, 
right ventricle and tricuspid valve has not been improved, 
and univentricular repair was planned for this patient. 
For this end, cardiac catheterization and angiography 
was performed 15 months after her combined procedure 
and her pulmonary index was found enough for Glenn’s 
anastomosis. 
At the same time, in the patient with double inlet left 
ventricle, double outlet left ventricle, pulmonary stenosis 
and left modiﬁ  ed Blalock-Taussig shunt (obstructed), the 
ﬂ  ow of ductal stent and oxygen saturation did not decrease 
until now. Elective univentricular repair was planned for 
this patient too. 
Balloon dilatation of ductal stent with a 4.5 mm coronary 
balloon was performed in a patient who has pulmonary 
atresia with intact ventricular septum and patent ductus 
arteriosus 1 month after his combined procedure 
including ductal stent implantation and perforation of 
atretic valve with subsequent pulmonary valvuloplasty, 
because of a narrowing in-stent diameter and decrease 
in oxygen saturation. After dilatation of ductal stent, 
oxygen saturation increased and stayed in normal levels 
at follow-up. 
Restenosis was not observed in patients who underwent 
aortic balloon valvuloplasty as a part of combined 
procedure during follow-up period except when a patient 
died. 
In one patient who has not suffered from aortic 
insufﬁ  ciency after combined procedure, minor aortic 
regurgitation developed after about 2 years. Other 
than this, in another patient mild aortic insufﬁ  ciency 
developed after combined procedure, aortic regurgitation 
increased from mild-to-moderate 18 months after aortic 
balloon valvuloplasty. In two patients developed mild 
aortic insufﬁ  ciency after combined procedure, aortic 
insufﬁ  ciency has been persisted as mild grade. The aortic 
regurgitation reduced to mild at follow-up, in a patient 
with moderate aortic regurgitation detected just after the 
combined procedure. 
Residual ductal shunt disappeared in 3 months in a case 
that a tiny residual defect was detected after embolization 
procedure. We did not detect any coil migration or stenosis 
at left pulmonary artery. 
A temporary pacemaker was positioned by intravenous 
route and dexamethazone was started to the patient who 
developed complete atrioventricular block after VSD 
closure. The patient recovered in 3 days. The case in which 
VSD was closed by non-detachable coil, the severity of 
the aortic regurgitation was reduced from mild-to-trace 
level in follow-up. 
DISCUSSION
With recent advances in interventional catheterization, 
single or combined transcatheter interventions made the 
surgical treatment easy in some multiple congenital cardiac 
diseases, and even disappeared the need for surgery in 
some.[1] 
Today, pulmonary balloon valvuloplasty has become 
the ﬁ  rst choice in nearly all of the valvuler pulmonary 
stenosis. Likewise, coarctation angioplasty and stenting 
procedures has became the procedure of choice in native 
and postoperative coarctation in selected cases.[6-8] Although 
aortic balloon valvuloplasty has been performed for 
palliation mostly, it may have provided the cure in some 
cases. In many centers in all around the world, transcatheter 
PDA closure, VSD, ASD, ﬁ  stule and collateral closure in 189
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selected cases, stent implantation to ductus, pulmonary 
artery and its branches have been carried through with 
success.[9-14] 
In cases with multiple congenital cardiac defects, different 
transcatheter interventions may be performed in several 
different sessions, or may be performed in the same session 
as a combined procedure.[15,16] The ﬁ  rst case of combined 
transcatheter intervention reported in the literature was 
a 7-year-old girl whose ASD was closed by an Amplatzer 
Septal occluder with pulmonary balloon valvuloplasty. 
Recently, reports on combined interventions have been 
increased tremendously.[17-19] 
Introduction of combined transcatheter procedures 
lessened the ratio of surgery needed cardiac lesions and 
decreased the mortality and morbidity related to surgery. 
In addition to this, combined procedures have led the 
surgery to be delayed to more elective conditions. In 
our series, at the follow-up of four cases that underwent 
aortic balloon valvuloplasty or coarctation angioplasty 
at before 6 months of age, there was no need to repeat 
the procedure. 
Today, surgery is recommended in neonatal and early 
infantile native aortic coarctation due to increased risk 
of recoarctation after balloon angioplasty. But if there 
is any accompanying lesion or systolic dysfunction, the 
combined transcatheter procedures may be the procedure 
of choice.  [20] A 1-month-old baby with LV systolic 
dysfunction underwent coarctation angioplasty with 
embolization of pulmonary sequestration in the same 
session. Recoarctation developed at the age of 3 and 5 
months and coarctation angioplasty was repeated. At the 
age of 9.5 months, the patient had to be sent for surgery 
by recurrence of recoarctation. 
Combined interventional procedures may totally obviate 
the need for surgery in some of the patients. We successfully 
closed five VSDs that fulfill the criteria for surgical 
closure. VSDs were closed by using different devices, 
and so obviated the need for surgery in these patients. In 
one of the patients, the indication for VSD closure was 
aortic regurgitation. In another patient, the indication was 
aortic valve prolapse and aortic regurgitation. The aortic 
regurgitation decreased from mild to trivial amount after 
procedure in both cases. 
In another patient with long-segment coarctation, 
successful stent implantation to diseased segment obviated 
the need for surgery and maintained the total cure for 
coarctation. 
Today, in selected cases ASDs and VSDs can be successfully 
closed with different devices.[21-26] Some authors reported 
ASD and VSD closures as the former procedure of a 
combined intervention, with an embolization of a PDA 
or a pulmonary balloon valvuloplasty performed after 
those procedures.[18,27,28] In our study, coil embolization of 
ductus in four and coarctation balloon angioplasty in one 
patient were successfully performed as second procedures 
of combined interventions after percutanous VSD closure 
as the ﬁ  rst procedure. The successful ASD closure was 
performed in the same session with ductus embolization 
in two, and with pulmonary balloon valvuloplasty in two 
patients.
Combined transcatheter interventions may sometimes 
obviate the need for some of the stages of a complex 
surgical procedure, in selected cases. For example, 
transcatheter pulmonary valvulotomy and valvuloplasty 
can be a treatment of choice for neonates with pulmonary 
atresia with intact ventricular septum, if there is a patent 
infundibulum, no right-ventricular-dependent coronary 
circulation, and adequate tricuspid valve and pulmonary 
valve.[29] In our series, a combined procedure of ductal-
stent implantation with retrograde perforation of atretic 
pulmonary valve and subsequent balloon valvuloplasty 
was performed in a patient with pulmonary atresia with 
intact ventricular septum with no RV-dependent coronary 
circulation and well- developed RV. On the other hand, in 
some patients planned univentricular repair, ductal stenting 
or palliative pulmonary balloon valvuloplasty can obviate 
the need for modiﬁ  ed Blalock-Taussig shunt. In our two 
cases planned univentricular repair, we have not needed 
performing the modiﬁ  ed Blalock-Taussig shunt until now. 
The advantages of the interventional treatment compared 
to the surgical approach are obvious. Although mortality is 
rarely seen after surgery, morbidity related to thoracotomy 
and pericardiotomy, cardiopulmonary bypass and possible 
risks of blood transfusions are more frequently observed.  [30] 
But it must be kept in mind that increased procedural time 
and ﬂ  uoroscopy time in combined procedures may be 
disadvantageous. Although the follow-up time is not long 
enough, we did not detect any complication in our cases.
All possible combinations can be considered for combined 
transcatheter procedures. But it is problematic to decide 
which procedure must be the followed ﬁ  rst. Song et al. 
suggested that the difﬁ  cult one must be the ﬁ  rst then the 
easy, the complex one ﬁ  rst and then the simple, and latter 
manipulations should not diminish the therapeutic effects 
of the former procedure.[18] For example, some authors 
advice to perform coarctation angioplasty ﬁ  rst and then Turkay, et al.: Combined interventional treatment
190 Journal of Cardiovascular Disease Research Vol. 1 / No 4
aortic balloon valvuloplasty, in patients having both valvular 
aortic stenosis and aortic coarctation. Contrarily some other 
authors argued that this is only a technical choice, and they 
did not report any serious hemodynamic problem in cases 
that they perform aortic valvuloplasty ﬁ  rst.[16] 
We performed aortic balloon valvuloplasty ﬁ  rst in ﬁ  ve 
patients, and coarctation angioplasty ﬁ  rst in one patient. In 
a two-day-old patient in a bad condition with LV systolic 
dysfunction, we performed the coarctation angioplasty 
ﬁ  rst, because we thought the coarctation had the more 
deleterious effect on the patient’s condition. In our series, 
we mostly choose the hemodynamically more important 
and harder procedure as the ﬁ  rst intervention. 
In conclusion, for the treatment of combined congenital 
cardiovascular defects, multiple transcatheter interventions 
in the same session are feasible, safe and effective with 
satisfactory good results. Second intervention may be 
performed as complementary procedure or independently 
to the ﬁ  rst intervention.
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